Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes
Fanny Jansson Sigfrids(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Carol Forsblom(University of Helsinki), Valma Harjutsalo(Research Council of Finland), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Niina Sandholm(University of Helsinki), Emma H. Dahlström(University of Helsinki)
Cited by 88
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k